Electrophysiologic effects of somatostatin in man. 1986

G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco

Experimental and clinical studies suggest that somatostatin, a regulatory peptide widely distributed in human tissues may have electrophysiologic effects. We studied a group of 14 patients who underwent a complete electrophysiologic study for different rhythm disturbances. Somatostatin significantly increased the spontaneous cycle length, the atrial and atrioventricular nodal effective refractory periods, and the Wenckebach cycle length. The AH and HV intervals during sinus rhythm remained unchanged. The effectiveness of somatostatin to interrupt paroxysmal supraventricular tachycardias was assessed in 18 patients. Termination was obtained in 15 (82.5%). Our results show that somatostatin has a significant electrophysiologic effect on the human heart, and confirm its clinical effectiveness in some arrhythmias.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D005260 Female Females
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D013614 Tachycardia, Paroxysmal Abnormally rapid heartbeats with sudden onset and cessation. Paroxysmal Reciprocal Tachycardia,Paroxysmal Reciprocal Tachycardias,Paroxysmal Tachycardia,Paroxysmal Tachycardias,Reciprocal Tachycardia, Paroxysmal,Reciprocal Tachycardias, Paroxysmal,Tachycardia, Paroxysmal Reciprocal,Tachycardias, Paroxysmal,Tachycardias, Paroxysmal Reciprocal

Related Publications

G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
August 1982, The Indian journal of medical research,
G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
June 1981, International journal of clinical pharmacology, therapy, and toxicology,
G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
August 1985, Archives des maladies du coeur et des vaisseaux,
G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
January 1978, Therapie,
G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
November 1981, Archives des maladies du coeur et des vaisseaux,
G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
January 1981, Journal of cardiovascular pharmacology,
G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
January 1987, The Canadian journal of cardiology,
G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
September 1978, The American journal of cardiology,
G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
January 1979, Acta chirurgica Scandinavica,
G Ghirlanda, and P Santarelli, and L Uccioli, and S Sandric, and F Bellocci, and G Bianchini, and P Cotroneo, and A V Greco
January 1978, Annales de l'anesthesiologie francaise,
Copied contents to your clipboard!